Thyrocare Technologies Ltd. Financials: Check Share Price, Balance Sheet, Annual Report, Quarterly Results, Shareholding, Company Profile and News for Company Analysis

Thyrocare Technologies Ltd. is a leading diagnostic and preventive care testing company in India. Established in 1995, Thyrocare has emerged as a trusted brand in the pathology sector with a robust network of more than 1 lakh healthcare centres across the country. The company offers a comprehensive range of services that include blood tests, preventive care, and wellness solutions. Thyrocare has built a reputation for providing high-quality services and accurate results at affordable prices.

Thyrocare Technologies Ltd. Share Price

The share price of Thyrocare Technologies Ltd. has displayed an upward trend since its initial public offering (IPO) in 2016. The company's shares were listed on the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE). As of [insert date], the shares were trading at [insert share price]. Thyrocare Technologies Ltd. has a market capitalization of [insert market cap], making it one of the top-performing stocks in the healthcare sector.

Thyrocare Technologies Ltd. Balance Sheet

Thyrocare Technologies Ltd. has a strong balance sheet, which is reflective of its industry expertise and sound financial management practices. The company has consistently reported robust revenue growth over the past few years, with its net profit increasing by [insert data] percent in [insert year]. Thyrocare's strong balance sheet is a testament to its commitment to maintaining excellent financial health.

Thyrocare Technologies Ltd. Annual Report

Thyrocare Technologies Ltd.'s annual report is a comprehensive document that provides detailed information on the company's operations, financial performance, and future prospects. The annual report for [insert year] can be downloaded from our website and provides investors with insights into the company's overall strategy and performance.

Thyrocare Technologies Ltd. Dividend

Thyrocare Technologies Ltd. has a consistent dividend payment history, making it an attractive investment option for income-seeking investors. The company's board of directors typically meets annually to decide on the dividend payout ratio. Investors can use our pre-built screening tools to evaluate Thyrocare's dividend yield and compare it with other industry players.

Thyrocare Technologies Ltd. Quarterly Result

Thyrocare Technologies Ltd.'s quarterly results provide a snapshot of the company's financial performance over the past few months. The results include key financial metrics such as revenue, earnings, and net profit. Our website provides access to the quarterly results and enables investors to analyse the company's performance over time. Our premium features allow for fair value calculation using tools such as DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis.

Thyrocare Technologies Ltd. Stock Price

Thyrocare Technologies Ltd.'s stock price is a crucial indicator of investor sentiment towards the company. The shares have historically shown a stable price trend, making it a consistent performer in the stock market. Investors can use our pre-built screening tools to track Thyrocare's stock price and compare it with other companies in the healthcare industry.

Thyrocare Technologies Ltd. Price Chart

Thyrocare Technologies Ltd.'s price chart is a visual representation of the company's stock price movement over time. Our website provides access to real-time price charts, which can be customized to show historical data, trends, and technical indicators. Price charts are an essential tool for investors to analyze the company's performance and make informed investment decisions.

Thyrocare Technologies Ltd. News

Thyrocare Technologies Ltd. news section provides investors with the latest updates and developments related to the company. The news section is updated regularly and covers a diverse range of topics such as new product launches, partnerships, and collaborations. Our news section is an excellent resource for investors who want to stay up-to-date with the company's activities.

Thyrocare Technologies Ltd. Concall Transcripts

Thyrocare Technologies Ltd.'s concall transcripts are available for download on our website. These transcripts provide investors with a detailed record of the company's earnings calls, which are held every quarter. The concall transcripts include discussions on the company's financial performance, industry trends, and future outlook. Investors can use these transcripts to gain valuable insights into the company's strategy and vision.

Thyrocare Technologies Ltd. Investor Presentations

Thyrocare Technologies Ltd.'s investor presentations are available for download on our website. These presentations provide a comprehensive overview of the company's operations, strategy, and performance. The presentations include key financial metrics, industry analysis, and forecasts. Investors can use Thyrocare's investor presentations to make informed investment decisions and assess the company's growth prospects.

Thyrocare Technologies Ltd. Promoters

Thyrocare Technologies Ltd.'s promoters are a group of highly experienced professionals who have been instrumental in the company's growth and success. The promoters include entrepreneurs, industry professionals, and experts with significant experience in the healthcare sector. The promoters of Thyrocare are committed to maintaining the company's reputation for quality and accuracy and have been successful in delivering consistent shareholder value.

Thyrocare Technologies Ltd. Shareholders

Thyrocare Technologies Ltd.'s shareholders include a diverse range of institutional and retail investors. The shareholders have reposed their trust in the company's management team and are confident of the company's prospects. Thyrocare's shareholders have been rewarded with consistent returns and steady capital appreciation over time.

In conclusion, Thyrocare Technologies Ltd. is a leading diagnostic and preventive care testing company in India. The company has a strong reputation for providing high-quality services at affordable prices and has consistently delivered strong financial performance. Investors can use our pre-built screening tools to evaluate the company's financial metrics and make informed investment decisions. Our website provides access to Thyrocare's annual reports, concall transcripts, investor presentations, credit ratings, and research reports, allowing investors to keep track of the company's performance and growth prospects. Our premium features, including fair value calculation tools, enable investors to perform a detailed analysis of the company's balance sheet, quarterly results, and profit and loss statements. 

Thyrocare Technologies Balance Sheet Analysis

Thyrocare Technologies, a prominent player in the healthcare sector, exhibits a robust balance sheet, revealing key financial insights over the past four years. Looking at the company's reserves, there is an evident growth trajectory from Rs 325.39 Cr in March 2020 to Rs 460.86 Cr by March 2024. However, it's worth noting that after reaching a peak in March 2023 at Rs 468.11 Cr, there was a slight decline by March 2024.

Thyrocare Technologies Debt Introduction

Interestingly, Thyrocare Technologies remained debt-free until March 2023, when borrowings entered the scene at just under Rs 11 Cr. This introduction of debt highlights a potential strategic shift in the company's capital structure, possibly indicating investment or expansion activities that could affect future growth.

Thyrocare Technologies Asset Growth

The asset side of the balance sheet reflects a positive outlook, with the net block increasing from Rs 110.39 Cr in March 2020 to Rs 158.29 Cr by March 2024, signaling ongoing investment in property, plant, and equipment. Furthermore, investments grew steadily to Rs 176.20 Cr, pointing towards effective capital allocation.

Current Assets and Liabilities

A significant jump was observed in current assets from Rs 113.27 Cr in March 2020 to Rs 381.76 Cr in March 2022, before settling at Rs 245.65 Cr by March 2024. Current liabilities followed a somewhat erratic pattern, peaking in March 2022 at Rs 211.03 Cr and later receding to Rs 75.96 Cr.

Reflecting on Thyrocare's Financial Health

The data presents an analysis for the Standalone Balance Sheet of Thyrocare Technologies. It is integral for investors to monitor such financial movements within healthcare entities like Thyrocare Technologies, amidst market trends and sectoral shifts, aiding in informed decision-making without suggesting any investment action.

Note: This analysis allows investors to screen for potential opportunities and understand the financial standings of Thyrocare Technologies relative to market trends and indices such as the BSE and NSE. 

Thyrocare Technologies Reserves

Between Mar 2020 and Mar 2023, Thyrocare Technologies showcased a notable increase in its total reserves, climbing from Rs 325.39 Cr to Rs 468.11 Cr. However, there was a slight decline observed in Mar 2024, with reserves standing at Rs 460.86 Cr.

Thyrocare Technologies Balance Sheet Evolution

Reviewing Thyrocare Technologies’ balance sheet over the span of four years, from Mar 2020 to Mar 2024, the company has managed to significantly increase its total liabilities and assets from Rs 430.75 Cr to Rs 596.10 Cr. This indicates overall growth in the size of the company's financial stature.

Thyrocare Technologies Debt Profile

A substantial change in Thyrocare Technologies' borrowing status was observed in Mar 2024, where the figure went from zero to Rs 10.91 Cr, marking the introduction of debt into the company's capital structure.

Thyrocare Technologies Assets Analysis

In terms of assets, there has been a steady increase in Thyrocare Technologies' net block from Rs 110.39 Cr in Mar 2020 to Rs 158.29 Cr in Mar 2024, showing growth in the company's property and equipment investments. Current assets saw a peak at Rs 381.76 Cr in Mar 2022 before reducing to Rs 245.65 Cr in Mar 2024.

The data is an analysis for the Standalone Balance Sheet of the company.

In the context of market dynamics, Thyrocare Technologies forms part of the healthcare sector, which is often monitored by investors for its potential resistance to economic downturns and as a gauge for the sector's innovation.